Physician profile
Michael Richard Hee
NPI 1801891551
$1,918.14
in general payments reported to CMS, 2019-2025
17 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $102 · 2021: $71.11 · 2022: $144 · 2023: $454 · 2024: $418 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.57 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $214.45 | 2022-2024 | Acthar |
| Abbvie INC. | $211.38 | 2022-2024 | |
| Biotissue Holdings INC. | $188.74 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $174.48 | 2024-2025 | Xdemvy |
| Allergan, INC. | $161.61 | 2019-2020 | |
| Amgen INC. | $150.57 | 2024-2025 | Tepezza |
| Sun Pharmaceutical Industries INC. | $135.71 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $130.90 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $126.58 | 2023-2025 | Rocklatan, Eysuvis, Clareon |
| Thea Pharma INC. | $102.53 | 2023-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $82.01 | 2023-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $61.00 | 2024-2025 | Vevye |
| Glaukos Corporation | $46.63 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Aerie Pharmaceuticals, INC. | $36.11 | 2020-2021 | |
| Rxsight INC | $34.46 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $34.36 | 2024 | Eylea Hd |
| Horizon Therapeutics Plc | $26.62 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.